Literature DB >> 15752876

Application of the No Action Level (NAL) protocol to correct for prostate motion based on electronic portal imaging of implanted markers.

Hans C J de Boer1, Marjolein J H van Os, Peter P Jansen, Ben J M Heijmen.   

Abstract

PURPOSE: To evaluate the efficacy of the No Action Level (NAL) off-line correction protocol in the reduction of systematic prostate displacements as determined from electronic portal images (EPI) using implanted markers. METHODS AND MATERIALS: Four platinum markers, two near the apex and two near the base of the prostate, were implanted for localization purposes in patients who received fractionated high dose rate brachytherapy. During the following course of 25 fractions of external beam radiotherapy, the position of each marker relative to the corresponding position in digitally reconstructed radiographs (DRRs) was measured in EPI in 15 patients for on average 17 fractions per patient. These marker positions yield the composite displacements due to both setup error and internal prostate motion, relative to the planning computed tomography scan. As the NAL protocol is highly effective in reducing systematic errors (recurring each fraction) due to setup inaccuracy alone, we investigated its efficacy in reducing systematic composite displacements. The analysis was performed for the center of mass (COM) of the four markers, as well as for the cranial and caudal markers separately. Furthermore, the impact of prostate rotation on the achieved positioning accuracy was determined.
RESULTS: In case of no setup corrections, the standard deviations of the systematic composite displacements of the COM were 3-4 mm in the craniocaudal and anterior-posterior directions, and 2 mm in the left-right direction. The corresponding SDs of the random displacements (interfraction fluctuations) were 2-3 mm in each direction. When applying a NAL protocol based on three initial treatment fractions, the SDs of the systematic COM displacements were reduced to 1-2 mm. Displacements at the cranial end of the prostate were slightly larger than at the caudal end, and quantitative analysis showed this originates from left-right axis rotations about the prostate apex. Further analysis revealed that significant time trends are present in these prostate rotations. No significant trends were observed for the prostate translations.
CONCLUSIONS: The NAL protocol based on marker positions in EPI halved the composite systematic displacements using only three imaged fractions per patient, and thus allowed for a significant reduction of planning margins. Although large rotations of the prostate, and time trends therein, were observed, the net impact on the measured displacements and on the accuracy obtained with NAL was small.

Entities:  

Mesh:

Year:  2005        PMID: 15752876     DOI: 10.1016/j.ijrobp.2004.09.035

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  24 in total

1.  Uncertainties and CTV to PTV margins quantitative assessment using cone-beam CT technique in clinical application for prostate, and head and neck irradiation tumours.

Authors:  X J Juan-Senabre; J López-Tarjuelo; A Conde-Moreno; A Santos-Serra; A L Sánchez-Iglesias; J D Quirós-Higueras; N de Marco Blancas; S Calzada-Feliu; C Ferrer-Albiach
Journal:  Clin Transl Oncol       Date:  2011-11       Impact factor: 3.405

2.  Toxicity after intensity-modulated, image-guided radiotherapy for prostate cancer.

Authors:  Matthias Guckenberger; Sami Ok; Bülent Polat; Reinhart A Sweeney; Michael Flentje
Journal:  Strahlenther Onkol       Date:  2010-09-30       Impact factor: 3.621

3.  Effect of magnesium oxide on interfraction prostate motion and rectal filling in prostate cancer radiotherapy: analysis of a randomized clinical trial.

Authors:  Annemarie M den Harder; Carla H van Gils; Alexis N T J Kotte; Marco van Vulpen; Irene M Lips
Journal:  Strahlenther Onkol       Date:  2014-04-24       Impact factor: 3.621

Review 4.  kV cone-beam CT-based IGRT: a clinical review.

Authors:  Judit Boda-Heggemann; Frank Lohr; Frederik Wenz; Michael Flentje; Matthias Guckenberger
Journal:  Strahlenther Onkol       Date:  2011-04-26       Impact factor: 3.621

5.  Modeling positioning uncertainties of prostate cancer external beam radiation therapy using pre-treatment data.

Authors:  Per Munck af Rosenschöld; Neil B Desai; Jung Hun Oh; Aditya Apte; Margie Hunt; Abraham Kalikstein; James Mechalakos; Laura Happersett; Joseph O Deasy; Michael J Zelefsky
Journal:  Radiother Oncol       Date:  2014-02-20       Impact factor: 6.280

6.  [Image-guided intensity-modulated radiation therapy decreases late gastrointestinal side effects after radiation therapy for prostate cancer].

Authors:  Tobias Finazzi; Matthias Guckenberger
Journal:  Strahlenther Onkol       Date:  2017-02       Impact factor: 3.621

7.  Verification of the dose attenuation of a newly developed vacuum cushion for intensity-modulated radiation therapy of prostate cancer.

Authors:  Toru Takakura; Yoshiyuki Ito; Akinori Higashikawa; Tomohiro Nishiyama; Takashi Sakamoto
Journal:  Radiol Phys Technol       Date:  2016-06-03

8.  Pretreatment verification of dose calculation and delivery by means of measurements with PLEXITOM™ phantom.

Authors:  Paweł Wołowiec; Paweł Kukołowicz; Krzysztof Lis
Journal:  Rep Pract Oncol Radiother       Date:  2013-02-04

9.  Technical note: improved positioning protocol for patient setup accuracy in conventional radiotherapy for lung cancer.

Authors:  Hongbo Chai; Yuichiro Narita; Masafumi Takagi; Mikiko Kudo; Tomomi Kimura; Keiichi Kattou
Journal:  Radiol Phys Technol       Date:  2019-09-23

10.  Moderately hypofractionated radiotherapy for localized prostate cancer: long-term outcome using IMRT and volumetric IGRT.

Authors:  M Guckenberger; I Lawrenz; M Flentje
Journal:  Strahlenther Onkol       Date:  2013-11-08       Impact factor: 3.621

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.